Literature DB >> 33907400

Rosuvastatin Nanomicelles Target Neuroinflammation and Improve Neurological Deficit in a Mouse Model of Intracerebral Hemorrhage.

Liu Zi1,2, Wencheng Zhou1,3, Jiake Xu1,4, Junshu Li5, Ning Li2, Jianguo Xu1,4,6, Chao You1,4,6, Chengwei Wang1,2, Meng Tian1,4,6.   

Abstract

BACKGROUND: Intracerebral hemorrhage (ICH), a devastating subtype of stroke, has a poor prognosis. However, there is no effective therapy currently available due to its complex pathological progression, in which neuroinflammation plays a pivotal role in secondary brain injury. In this work, the use of statin-loaded nanomicelles to target the neuroinflammation and improve the efficacy was studied in a mouse model of ICH.
METHODS: Rosuvastatin-loaded nanomicelles were prepared by a co-solvent evaporation method using polyethylene glycol-poly(ε-caprolactone) (PEG-PCL) copolymer as a carrier. The prepared nanomicelles were characterized by transmission electron microscopy (TEM) and dynamic light scattering (DLS), and then in vitro and in vivo studies were performed.
RESULTS: TEM shows that the nanomicelles are spherical with a diameter of about 19.41 nm, and DLS shows that the size, zeta potential, and polymer dispersity index of the nanomicelles were 23.37 nm, -19.2 mV, and 0.221, respectively. The drug loading content is 8.28%. The in vivo study showed that the nanomicelles significantly reduced neuron degeneration, inhibited the inflammatory cell infiltration, reduced the brain edema, and improved neurological deficit. Furthermore, it was observed that the nanomicelles promoted the polarization of microglia/macrophages to M2 phenotype, and also the expression of the proinflammatory cytokines, such as IL-1β and TNF-α, was significantly down-regulated, while the expression of the anti-inflammatory cytokine IL-10 was significantly up-regulated. The related mechanism was proposed and discussed.
CONCLUSION: The nanomicelles treatment suppressed the neuroinflammation that might contribute to the promoted nerve functional recovery of the ICH mouse, making it potential to be applied in clinic.
© 2021 Zi et al.

Entities:  

Keywords:  intracerebral hemorrhage; nanomicelles; neuroinflammation; rosuvastatin

Mesh:

Substances:

Year:  2021        PMID: 33907400      PMCID: PMC8068519          DOI: 10.2147/IJN.S294916

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  50 in total

1.  Modulation of human T cells signaling transduction by lovastatin.

Authors:  Shu-Meng Cheng; Jenn-Haung Lai; Shih-Ping Yang; Tien-Ping Tsao; Ling-Jun Ho; Jun-Ting Liou; Cheng-Chung Cheng
Journal:  Int J Cardiol       Date:  2008-11-28       Impact factor: 4.164

Review 2.  Role and mechanisms of cytokines in the secondary brain injury after intracerebral hemorrhage.

Authors:  Huimin Zhu; Zhiqiang Wang; Jixu Yu; Xiuli Yang; Feng He; Zhenchuan Liu; Fengyuan Che; Xuemei Chen; Honglei Ren; Michael Hong; Jian Wang
Journal:  Prog Neurobiol       Date:  2019-03-25       Impact factor: 11.685

Review 3.  Hemostatic nanotechnologies for external and internal hemorrhage management.

Authors:  Liying Wang; Xinru You; Chunlei Dai; Tong Tong; Jun Wu
Journal:  Biomater Sci       Date:  2020-07-13       Impact factor: 6.843

4.  Pinocembrin protects hemorrhagic brain primarily by inhibiting toll-like receptor 4 and reducing M1 phenotype microglia.

Authors:  Xi Lan; Xiaoning Han; Qian Li; Qiang Li; Yufeng Gao; Tian Cheng; Jieru Wan; Wei Zhu; Jian Wang
Journal:  Brain Behav Immun       Date:  2016-12-20       Impact factor: 7.217

Review 5.  Cellular and molecular mechanisms of statins: an update on pleiotropic effects.

Authors:  Mamoru Satoh; Yuji Takahashi; Tsuyoshi Tabuchi; Yoshitaka Minami; Makiko Tamada; Kan Takahashi; Tomonori Itoh; Yoshihiro Morino; Motoyuki Nakamura
Journal:  Clin Sci (Lond)       Date:  2015-07       Impact factor: 6.124

6.  Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury.

Authors:  Yan-Chun Wang; Peng-Fei Wang; Huang Fang; Jing Chen; Xiao-Yi Xiong; Qing-Wu Yang
Journal:  Stroke       Date:  2013-07-09       Impact factor: 7.914

7.  Simvastatin accelerates hematoma resolution after intracerebral hemorrhage in a PPARγ-dependent manner.

Authors:  Yuelong Wang; Qianwei Chen; Qiang Tan; Zhou Feng; Zhenlin He; Jun Tang; Hua Feng; Gang Zhu; Zhi Chen
Journal:  Neuropharmacology       Date:  2017-10-17       Impact factor: 5.250

8.  HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage.

Authors:  Keun-Hwa Jung; Kon Chu; Sang-Wuk Jeong; So-Young Han; Soon-Tae Lee; Jin-Young Kim; Manho Kim; Jae-Kyu Roh
Journal:  Stroke       Date:  2004-05-27       Impact factor: 7.914

9.  Targeted delivery of ginsenoside compound K using TPGS/PEG-PCL mixed micelles for effective treatment of lung cancer.

Authors:  Lei Yang; Zhenghai Zhang; Jian Hou; Xin Jin; Zhongcheng Ke; Dan Liu; Mei Du; Xiaobing Jia; Huixia Lv
Journal:  Int J Nanomedicine       Date:  2017-10-17

10.  Copper Sulfide Nanoparticles-Incorporated Hyaluronic Acid Injectable Hydrogel With Enhanced Angiogenesis to Promote Wound Healing.

Authors:  Wencheng Zhou; Liu Zi; Ying Cen; Chao You; Meng Tian
Journal:  Front Bioeng Biotechnol       Date:  2020-05-08
View more
  3 in total

1.  Hypoxia-preconditioned mesenchymal stem cells attenuate microglial pyroptosis after intracerebral hemorrhage.

Authors:  Jianyang Liu; Jialin He; Yan Huang; Lite Ge; Han Xiao; Liuwang Zeng; Zheng Jiang; Ming Lu; Zhiping Hu
Journal:  Ann Transl Med       Date:  2021-09

Review 2.  Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer.

Authors:  Yoichi Morofuji; Shinsuke Nakagawa; Kenta Ujifuku; Takashi Fujimoto; Kaishi Otsuka; Masami Niwa; Keisuke Tsutsumi
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-26

Review 3.  Nanomedicine: An Emerging Novel Therapeutic Strategy for Hemorrhagic Stroke.

Authors:  Yating Xu; Anqi Chen; Jiehong Wu; Yan Wan; Mingfeng You; Xinmei Gu; Hongxiu Guo; Sengwei Tan; Quanwei He; Bo Hu
Journal:  Int J Nanomedicine       Date:  2022-05-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.